Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol-Remifentanil for Conscious Sedation in TAVI
NCT07532733Recruiting
- Sponsor
- Erasmus Hospital
- Start
- Apr 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in aortic stenosis (AS) (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Occurrence of an intraoperative respiratory event. Started Apr 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT07532733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532733.